FASN and non-small cell lung carcinoma: In order to ascertain whether the EGFR‐FASN regulatory network was active in other Gefitinib‐resistant NSCLC cells, carrying either wild‐type EGFR or different EGFR mutations, we examined H1975 (EGFR T790M/L858R) and H1703 (EGFR wild‐type) cells (Appendix Table S3).